BNTX

#494
BioNTech SE - American Depositary Shares
95.9 5 USD
+2.10%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
95.95
95.95
Range Annuel
79.52
123.98
Changement quotidien
+2.10%
Changement Mensuel
-6.21%
Evolution sur 6 mois
-5.00%
Changement Annuel
-0.47%
Clôture Précédente
93.9 8
Open
95.9 5
Low
95.9 5
High
95.9 5
Volume
111
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

BioNTech SE - American Depositary Shares

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic.

Nouvelles